The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract Win

24 Aug 2010 07:00

INTERSERVE APPOINTED TO £4.5bn PROCURE21+ NHS FRAMEWORK AGREEMENT

Interserve, the international services, maintenance and building group, has been named as one of the six Principal Supply Chain Partners (PCSPs) in the new ProCure21+ framework agreement, estimated to be worth up to £4.5 billion over its six-year term.

ProCure21+ will begin operating on 1st October 2010. It is a new framework that will replace the current ProCure21 programme through which Interserve has undertaken 136 schemes on behalf of 52 NHS Trusts since its pilot in 2002. Like ProCure21 the framework will streamline and improve the procurement process for NHS Trusts across England. This will enable them to select an appropriate supply chain partner to deliver acute, primary care and mental health facilities. As with ProCure21, there is a commitment to long-term relationships, collaborative working, integrated supply chains and the use of target-cost contracts.

There are a number of new features in ProCure21+ including:

* A centrally-provided risk evaluation tool for all schemes to improve

consistency and share approaches to managing common risks.

* A central repository of technical drawings and information that can be

re-used by all clients and supply-chain members under the "NHS Royalty-Free

Licence".

* An online "monthly monitoring" performance management system with a reduced

benchmarking data set to manage scheme performance centrally.

* Provision of a project start-up workshop by PCSPs on all schemes to align

stakeholder and supply chain requirements early in the process.

* Assurance of a VAT-compliant PSCP structure to maximise VAT recovery for

NHS Clients.

Commenting on Interserve's selection as a Principal Supply Chain Partner, Adrian Ringrose, Chief Executive, said, "The creation of ProCure21+ is excellent news. Under ProCure21 Interserve has been able to deliver many high-quality, value-for-money facilities and ProCure21+ will enable us to continue enhancing the health environment to meet the changing needs of the NHS. We are well positioned to do this as the only Health Framework Partner supporting the NHS across England, Scotland and Wales."

- Ends -

For further information please contact:

Amanda Cardall 0121 331 8125 Corporate Marketing Manager Elizabeth Morley / Tom Eckersley 020 7379 5151

Maitland About Interserve

Over the last five years Interserve has delivered healthcare projects with a total value of approximately £500 million, most of which has been through ProCure21.

Interserve's vision is to be the Trusted Partner of all our stakeholders. We are one of the world's foremost support services and construction companies, operating in the public and private sectors in the UK and internationally. We offer advice, design, construction and facilities management services for society's infrastructure and provide a range of plant and equipment in specialist fields. Interserve is based in the UK. It has revenue of £1.9 billion and a workforce of 50,000 people worldwide.

Health website: www.health.interserve.com

General website: www.interserve.com.

vendor
Date   Source Headline
18th Oct 20179:25 amRNSHolding(s) in Company
16th Oct 201710:04 amRNSDirector/PDMR Shareholding
16th Oct 20177:30 amRNSStatement following recent media coverage
12th Oct 20173:46 pmRNSDirector/PDMR Shareholding
9th Oct 20177:00 amRNSInterserve wins Leeds housing development contract
6th Oct 20179:08 amRNSHolding(s) in Company
5th Oct 20178:50 amRNSHolding(s) in Company
3rd Oct 20172:15 pmRNSDirector/PDMR Shareholding
3rd Oct 20177:00 amRNSInterserve-led consortium chosen for £85m project
2nd Oct 20177:00 amRNSSection 430 (2B) Companies Act Statement
29th Sep 201711:33 amRNSHolding(s) in Company
27th Sep 20177:00 amRNSInterserve wins place on £8bn CMA framework
26th Sep 201710:49 amRNSHolding(s) in Company
26th Sep 201710:42 amRNSHolding(s) in Company
20th Sep 20179:03 amRNSHolding(s) in Company
19th Sep 20174:26 pmRNSHolding(s) in Company
19th Sep 20179:45 amRNSHolding(s) in Company
19th Sep 20177:00 amRNSHolding(s) in Company
18th Sep 20172:09 pmRNSDirector/PDMR Shareholding
18th Sep 20171:48 pmRNSHolding(s) in Company
18th Sep 201712:00 pmRNSDirector/PDMR Shareholding
18th Sep 201710:08 amRNSHolding(s) in Company
18th Sep 201710:04 amRNSHolding(s) in Company
18th Sep 20177:00 amRNSMark Whiteling appointed Chief Financial Officer
15th Sep 20173:33 pmRNSHolding(s) in Company
15th Sep 20172:16 pmRNSDirector/PDMR Shareholding
14th Sep 20177:00 amRNSTrading Update
13th Sep 20179:18 amRNSDirector/PDMR Shareholding
12th Sep 201711:44 amRNSDirector/PDMR Shareholding
12th Sep 201710:16 amRNSHolding(s) in Company
11th Sep 201711:13 amRNSHolding(s) in Company
6th Sep 20179:24 amRNSHolding(s) in Company
6th Sep 20177:00 amRNSInterserve wins £90m DfT FM contract
1st Sep 20177:00 amRNSSection 430 (2B) Companies Act Statement
29th Aug 201711:42 amRNSHolding(s) in Company
24th Aug 20174:27 pmRNSHolding(s) in Company
24th Aug 201710:42 amRNSHolding(s) in Company
24th Aug 20179:18 amRNSPublication of Half-Year Report
24th Aug 20178:46 amRNSHolding(s) in Company
17th Aug 20179:33 amRNSHolding(s) in Company
16th Aug 20177:00 amRNSInterserve and Amec Foster Wheeler Joint Venture
14th Aug 20172:17 pmRNSHolding(s) in Company
14th Aug 20172:16 pmRNSHolding(s) in Company
9th Aug 20173:01 pmRNSDirector/PDMR Shareholding
9th Aug 20177:00 amRNSHalf-Year Results 2017
13th Jul 20174:25 pmRNSDirector/PDMR Shareholding
12th Jul 201712:52 pmRNSDirector/PDMR Shareholding
12th Jul 20179:44 amRNSHolding(s) in Company
3rd Jul 20177:00 amRNSBlock listing Interim Review
30th Jun 20177:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.